Actionnariat et activité des initiés pour Adicet Bio, Inc. (ACET): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $9.05 |
| Capitalisation | $85M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-05 | Klickstein Lloyd | A-Award | 18,300 | $168K |
| 2026-06-19 | Schor Chen | A-Award | 55,000 | $446K |
| 2026-06-19 | Aftab Blake | A-Award | 55,000 | $446K |
| 2026-06-21 | DUBIN STEVE | A-Award | 4,200 | $34K |
| 2026-06-21 | Chodakewitz Jeffrey | A-Award | 4,200 | $34K |
| 2026-06-21 | Grissinger Michael | A-Award | 4,200 | $34K |
| 2026-06-21 | Sinclair Andrew | A-Award | 4,200 | $34K |
| 2026-06-21 | Peng Katie | A-Award | 4,200 | $34K |
| 2026-06-21 | Klickstein Lloyd | A-Award | 4,200 | $34K |
| 2026-04-27 | RA CAPITAL MANAGEMENT, L.P. | J-Other | 250,000 | $25 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $66.8M | $53.3M | $7.0M | $10.6M | $84.3M | $277.5M | $257.7M | $159.7M | $56.5M | $38.9M |
| Placements à Court Terme | $881000 | 0 | $101.0M | $51.8M | $10.3M | 0 | 0 | 0 | $119.8M | $119.6M |
| Créances | $167.6M | 0 | 0 | $935000 | $2.7M | $214000 | $435000 | 0 | 0 | $342000 |
| Stocks | $98.1M | $136.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $352.7M | $54.2M | $109.5M | $64.2M | $100.3M | $282.4M | $261.0M | $162.3M | $180.1M | $160.9M |
| Immobilisations Corporelles | $10.0M | $39000 | $321000 | $2.1M | $25.9M | $35.0M | $49.0M | $44.2M | $36.8M | $28.5M |
| Goodwill | $67.9M | $237.0M | 0 | 0 | $20.1M | $19.5M | $19.5M | 0 | 0 | 0 |
| Actifs Incorporels | $79.1M | $285.1M | 0 | 0 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $540.8M | $55.2M | $109.9M | $81.6M | $153.8M | $338.9M | $330.7M | $207.3M | $220.2M | $192.4M |
| Dettes Fournisseurs | 0 | $1.5M | $538000 | $1.1M | $1.6M | $3.3M | $4.4M | $2.6M | $4.8M | $4.7M |
| Dette à Court Terme | $197000 | $14.5M | 0 | 0 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $98.9M | $5.5M | $5.7M | $14.9M | $22.5M | $16.3M | $19.7M | $19.3M | $19.4M | $21.5M |
| Dette à Long Terme | $118.6M | $339.2M | $3.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $236.3M | $5.5M | $5.7M | $142.0M | $44.0M | $35.8M | $38.4M | $37.1M | $33.6M | $33.1M |
| Réserves | $194.8M | -$33.8M | -$71.4M | -$69.6M | -$106.3M | -$168.3M | -$238.1M | -$380.8M | -$497.9M | -$614.7M |
| Capitaux Propres | $304.4M | $49.7M | $104.2M | -$60.4M | $109.8M | $303.1M | $292.3M | $170.2M | $186.6M | $159.2M |
| Dette Totale | $118.8M | $353.7M | $3.1M | 0 | $21.6M | $20.9M | $21.0M | $20.9M | $17.2M | $14.7M |
| Dette Nette | $51.1M | $300.3M | -$104.9M | -$62.4M | -$73.0M | -$256.6M | -$236.6M | -$138.8M | -$159.1M | -$143.8M |
| Fonds de Roulement | $253.8M | $48.7M | $103.8M | $49.3M | $77.9M | $266.1M | $241.3M | $143.0M | $160.7M | $139.4M |
Santé financière
| Dette / Capitaux propres | 0.11 |
| Ratio de liquidité | 6.71 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -4.65 |
Rentabilité
| Rentabilité des capitaux propres | -74.90% |
| Rentabilité du capital investi | -77.98% |
| Rentabilité des actifs | -66.80% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACRV · ADAG · CRVO · GANX · HOWL · IMUX · IOBT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ACET: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions